BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15630882)

  • 1. [Management of advanced stage ovarian cancer].
    Morice P; Camatte S; Lhomme C; Duvillard P; Castaigne D
    Rev Prat; 2004 Oct; 54(16):1777-86. PubMed ID: 15630882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?].
    Morice P; Leblanc E; Narducci F; Pomel C; Pautier P; Chevalier A; Lhommé C; Castaigne D
    Gynecol Obstet Fertil; 2005; 33(1-2):55-63. PubMed ID: 15752668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early debulking surgery after chemotherapy in advanced cancer of the ovary].
    de Gramont A; Pigné A; Louvet C; Sezeur A; Marpeau L; Vaillant JC; Cady J; Varette C; Demuynck B; Couturier JY; Lagadec B; Milliez J; Barrat J; Krulik M
    Ann Chir; 1997; 51(10):1069-76. PubMed ID: 10868028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer.
    Colombo N; Van Gorp T; Parma G; Amant F; Gatta G; Sessa C; Vergote I
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):159-79. PubMed ID: 17018256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of early-stage ovarian cancer.
    Schilder RJ; Young RC
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):867-77. PubMed ID: 1500390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of epithelial ovarian cancer.
    Schwartz PE
    Minerva Ginecol; 2003 Aug; 55(4):315-26. PubMed ID: 14581856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
    Zivanovic O; Braun M; Park TW; Kuhn W
    Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of recurrent epithelial ovarian carcinoma.
    Vasey PA
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):269-77. PubMed ID: 16029291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of epithelial ovarian cancer].
    Langmár Z; Csömör S
    Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer: a focus on management of recurrent disease.
    Herzog TJ; Pothuri B
    Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
    Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
    Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
    Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
    Möbus V; Wandt H; Frickhofen N; Bengala C; Champion K; Kimmig R; Ostermann H; Hinke A; Ledermann JA; ;
    J Clin Oncol; 2007 Sep; 25(27):4187-93. PubMed ID: 17698804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
    Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
    Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
    Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in treatment of epithelial ovarian cancer.
    Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
    Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.